GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Cyclically Adjusted PB Ratio

Corline Biomedical AB (OSTO:CLBIO) Cyclically Adjusted PB Ratio : 3.11 (As of Jun. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Corline Biomedical AB Cyclically Adjusted PB Ratio?

As of today (2024-06-15), Corline Biomedical AB's current share price is kr12.35. Corline Biomedical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr3.97. Corline Biomedical AB's Cyclically Adjusted PB Ratio for today is 3.11.

The historical rank and industry rank for Corline Biomedical AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:CLBIO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.54   Med: 2.71   Max: 3.02
Current: 2.77

During the past years, Corline Biomedical AB's highest Cyclically Adjusted PB Ratio was 3.02. The lowest was 2.54. And the median was 2.71.

OSTO:CLBIO's Cyclically Adjusted PB Ratio is ranked worse than
65.25% of 659 companies
in the Biotechnology industry
Industry Median: 1.73 vs OSTO:CLBIO: 2.77

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Corline Biomedical AB's adjusted book value per share data for the three months ended in Mar. 2024 was kr4.265. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr3.97 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Corline Biomedical AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Corline Biomedical AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corline Biomedical AB Cyclically Adjusted PB Ratio Chart

Corline Biomedical AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Corline Biomedical AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 3.00

Competitive Comparison of Corline Biomedical AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Corline Biomedical AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corline Biomedical AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Cyclically Adjusted PB Ratio falls into.



Corline Biomedical AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Corline Biomedical AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.35/3.97
=3.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corline Biomedical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Corline Biomedical AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.265/132.2054*132.2054
=4.265

Current CPI (Mar. 2024) = 132.2054.

Corline Biomedical AB Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.805 100.541 1.059
201406 0.000 100.432 0.000
201409 0.000 100.161 0.000
201412 0.552 100.225 0.728
201503 0.000 99.950 0.000
201506 2.471 99.995 3.267
201509 2.364 100.228 3.118
201512 2.139 100.276 2.820
201603 1.975 100.751 2.592
201606 3.173 101.019 4.153
201609 3.073 101.138 4.017
201612 2.957 102.022 3.832
201703 2.721 102.022 3.526
201706 2.566 102.752 3.302
201709 3.180 103.279 4.071
201712 3.066 103.793 3.905
201803 2.947 103.962 3.748
201806 3.887 104.875 4.900
201809 3.491 105.679 4.367
201812 3.388 105.912 4.229
201903 3.205 105.886 4.002
201906 3.695 106.742 4.576
201909 3.583 107.214 4.418
201912 3.459 107.766 4.243
202003 3.313 106.563 4.110
202006 3.163 107.498 3.890
202009 3.037 107.635 3.730
202012 2.791 108.296 3.407
202103 3.596 108.360 4.387
202106 4.448 108.928 5.399
202109 4.352 110.338 5.214
202112 4.292 112.486 5.044
202203 4.252 114.825 4.896
202206 4.293 118.384 4.794
202209 4.384 122.296 4.739
202212 4.401 126.365 4.604
202303 4.449 127.042 4.630
202306 4.362 129.407 4.456
202309 4.370 130.224 4.437
202403 4.265 132.205 4.265

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Corline Biomedical AB  (OSTO:CLBIO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Corline Biomedical AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Corline Biomedical AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Corline Biomedical AB (OSTO:CLBIO) Business Description

Traded in Other Exchanges
N/A
Address
Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Corline Biomedical AB (OSTO:CLBIO) Headlines

No Headlines